The results showed that serum β-CTX level and the ratio of β-CTX to PINP were significantly higher in the MBD group than in the healthy control group (p < .01), which meant β- CTX could effectively reflect the degree of bone damage in MM patients. This evidence concerns the gene CYP27A1 and Miyoshi myopathy.